Results 21 to 30 of about 35,039,938 (235)

One-step synthesis of poly(lactic-co-glycolic acid)-g-poly-1-vinylpyrrolidin-2-one copolymers

open access: yes, 2016
The radical polymerization of 1-vinylpyrrolidin-2-one (NVP) in poly(lactic-co-glycolic acid) (PLGA) 50: 50 at 100 degrees C leads to amphiphilic PLGA-g-PVP copolymers. Their composition is determined by FT-IR spectroscopy.
A. Manfredi   +3 more
core   +1 more source

Current Applications of Raman Spectroscopy in Intraoperative Neurosurgery

open access: yesBiomedicines
Background: Neurosurgery demands exceptional precision due to the brain’s complex and delicate structures, necessitating precise targeting of pathological targets.
Daniel Rivera   +8 more
doaj   +1 more source

G-stability one-leg hybrid methods for solving DAEs

open access: yesAdvances in Difference Equations, 2019
This paper introduces the solution of differential algebraic equations using two hybrid classes and their twin one-leg with improved stability properties.
P. Agarwal   +2 more
doaj   +1 more source

Workshop: BIM4EEB: A BIM-Based Toolkit for Efficient rEnovation in Buildings

open access: yesProceedings, 2021
On October 29th the workshop corresponding to the mid-term conference of BIM4EEB (Acronym of BIM Based Toolkit for Efficient rEnovation in Buildings, Horizon Project under grant agreement N.
Bruno Daniotti   +33 more
doaj   +1 more source

Early Body Mass Index z‐Score Change and Resolution of Severe Malnutrition in Children With Sickle Cell Anemia in a Low‐Income Setting: A Prospective Single‐Arm Extension Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with sickle cell anemia (SCA) in low‐income settings are at risk of severe malnutrition, but optimal nutritional management has not been established. We evaluated an intensified ready‐to‐use therapeutic food (RUTF) regimen in children with persistent severe malnutrition after initial treatment and assessed whether early ...
Safiya Gambo   +9 more
wiley   +1 more source

Leave-one-out meta-analysis for the TNF-α-308 G>A under the dominant model.

open access: yes, 2018
Leave-one-out meta-analysis for the TNF-α-308 G>A under the dominant model.
Arun Kumar Basavaraj (5832734)   +4 more
core   +1 more source

Molecular Surveillance and Partial Genetic Characterization of Low-Pathogenic Avian Influenza A Viruses in Migrating Birds from Ukraine

open access: yesViruses
Wild migratory birds are the principal natural reservoir of influenza A viruses (IAVs) and play a central role in their evolution and global dissemination.
Anton Gerilovych   +4 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy